Monovisc injection

Monovisc® is an optimised, multi-joint hyaluronic acid injectable therapy designed to provide effective joint cushioning, lubrication and long-term support. Each single injection delivers a high concentration of 88 mg ultra-pure hyaluronic acid, formulated with an Optimised Hyaluronic Acid Triple Action Matrix.

The carefully selected and optimised range of hyaluronic acid molecular weights creates a matrix that enhances shock absorption, improves joint lubrication and supports endogenous hyaluronic acid stimulation, contributing to improved joint function and comfort.

Monovisc® is a trusted single-injection hyaluronic acid therapy with extensive global clinical use across multiple joints, offering long-lasting therapeutic support while preserving joint health and mobility.

Key advantages:

• Single injection delivering a high concentration of 88 mg hyaluronic acid

• Optimised range of molecular weights for prolonged therapeutic effect

• Triple action matrix supporting cushioning, lubrication and joint stimulation

• Lightly cross-linked formulation for optimised joint residence time

• Supports joint preservation, longevity and smooth joint motion

• Ultra-pure, non-avian derived hyaluronic acid

• Produced using a trusted fermentation technique with a low rate of mild injection reactions

• Suitable for use across multiple joints

Monovisc® is intended for professional medical use.